Literature DB >> 25091469

Cytosine deamination is a major cause of baseline noise in next-generation sequencing.

Guoli Chen1, Stacy Mosier, Christopher D Gocke, Ming-Tseh Lin, James R Eshleman.   

Abstract

BACKGROUND AND OBJECTIVES: As next-generation sequencing (NGS) becomes a major sequencing platform in clinical diagnostic laboratories, it is critical to identify artifacts that constitute baseline noise and may interfere with detection of low-level gene mutations. This is especially critical for applications requiring ultrasensitive detection, such as molecular relapse of solid tumors and early detection of cancer. We recently observed a ~10-fold higher frequency of C:G > T:A mutations than the background noise level in both wild-type peripheral blood and formalin-fixed paraffin-embedded samples. We hypothesized that these might represent cytosine deamination events, which have been seen using other platforms.
METHODS: To test this hypothesis, we pretreated samples with uracil N-glycosylase (UNG). Additionally, to test whether some of the cytosine deamination might be a laboratory artifact, we simulated the heat associated with polymerase chain reaction thermocycling by subjecting samples to thermocycling in the absence of polymerase. To test the safety of universal UNG pretreatment, we tested known positive samples treated with UNG.
RESULTS: UNG pretreatment significantly reduced the frequencies of these mutations, consistent with a biologic source of cytosine deamination. The simulated thermocycling-heated samples demonstrated significantly increased frequencies of C:G > T:A mutations without other baseline base substitutions being affected. Samples with known mutations demonstrated no decrease in our ability to detect these after treatment with UNG.
CONCLUSION: Baseline noise during NGS is mostly due to cytosine deamination, the source of which is likely to be both biologic and an artifact of thermocycling, and it can be reduced by UNG pretreatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25091469      PMCID: PMC4175022          DOI: 10.1007/s40291-014-0115-2

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN: 1177-1062            Impact factor:   4.074


  28 in total

1.  DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA.

Authors:  M Hofreiter; V Jaenicke; D Serre; A von Haeseler; S Pääbo
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

Review 2.  Mutagenicity, toxicity and repair of DNA base damage induced by oxidation.

Authors:  Svein Bjelland; Erling Seeberg
Journal:  Mutat Res       Date:  2003-10-29       Impact factor: 2.433

3.  A high frequency of sequence alterations is due to formalin fixation of archival specimens.

Authors:  C Williams; F Pontén; C Moberg; P Söderkvist; M Uhlén; J Pontén; G Sitbon; J Lundeberg
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  Genome sequencing in microfabricated high-density picolitre reactors.

Authors:  Marcel Margulies; Michael Egholm; William E Altman; Said Attiya; Joel S Bader; Lisa A Bemben; Jan Berka; Michael S Braverman; Yi-Ju Chen; Zhoutao Chen; Scott B Dewell; Lei Du; Joseph M Fierro; Xavier V Gomes; Brian C Godwin; Wen He; Scott Helgesen; Chun Heen Ho; Chun He Ho; Gerard P Irzyk; Szilveszter C Jando; Maria L I Alenquer; Thomas P Jarvie; Kshama B Jirage; Jong-Bum Kim; James R Knight; Janna R Lanza; John H Leamon; Steven M Lefkowitz; Ming Lei; Jing Li; Kenton L Lohman; Hong Lu; Vinod B Makhijani; Keith E McDade; Michael P McKenna; Eugene W Myers; Elizabeth Nickerson; John R Nobile; Ramona Plant; Bernard P Puc; Michael T Ronan; George T Roth; Gary J Sarkis; Jan Fredrik Simons; John W Simpson; Maithreyan Srinivasan; Karrie R Tartaro; Alexander Tomasz; Kari A Vogt; Greg A Volkmer; Shally H Wang; Yong Wang; Michael P Weiner; Pengguang Yu; Richard F Begley; Jonathan M Rothberg
Journal:  Nature       Date:  2005-07-31       Impact factor: 49.962

5.  In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

Authors:  Michiel S van der Heijden; Jonathan R Brody; David A Dezentje; Eike Gallmeier; Steven C Cunningham; Michael J Swartz; Angelo M DeMarzo; G Johan A Offerhaus; William H Isacoff; Ralph H Hruban; Scott E Kern
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.

Authors:  Nicholas C Turner; Christopher J Lord; Elizabeth Iorns; Rachel Brough; Sally Swift; Richard Elliott; Sydonia Rayter; Andrew N Tutt; Alan Ashworth
Journal:  EMBO J       Date:  2008-04-03       Impact factor: 11.598

7.  DNA cytosine methylation and heat-induced deamination.

Authors:  M Ehrlich; K F Norris; R Y Wang; K C Kuo; C W Gehrke
Journal:  Biosci Rep       Date:  1986-04       Impact factor: 3.840

8.  Mutagenic deamination of cytosine residues in DNA.

Authors:  B K Duncan; J H Miller
Journal:  Nature       Date:  1980-10-09       Impact factor: 49.962

9.  Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.

Authors:  Ming-Tseh Lin; Stacy L Mosier; Michele Thiess; Katie F Beierl; Marija Debeljak; Li-Hui Tseng; Guoli Chen; Srinivasan Yegnasubramanian; Hao Ho; Leslie Cope; Sarah J Wheelan; Christopher D Gocke; James R Eshleman
Journal:  Am J Clin Pathol       Date:  2014-06       Impact factor: 2.493

10.  A novel uracil-DNA glycosylase with broad substrate specificity and an unusual active site.

Authors:  Alessandro A Sartori; Sorel Fitz-Gibbon; Hanjing Yang; Jeffrey H Miller; Josef Jiricny
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

View more
  50 in total

1.  Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance.

Authors:  Masaya Suenaga; Jun Yu; Koji Shindo; Koji Tamura; Jose Alejandro Almario; Christopher Zaykoski; P Dane Witmer; Shahriar Fesharakizadeh; Michael Borges; Anne-Marie Lennon; Eun-Ji Shin; Marcia Irene Canto; Michael Goggins
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

2.  In reply.

Authors:  Shidong Jia; Liangxuan Zhang; Gary J Latham
Journal:  Oncologist       Date:  2015-04-10

3.  Validation Strategy for Ultrasensitive Mutation Detection.

Authors:  Marija Debeljak; Michael Noë; Stacy L Riel; Lisa M Haley; Alexis L Norris; Derek A Anderson; Emily M Adams; Masaya Suenaga; Katie F Beierl; Ming-Tseh Lin; Michael G Goggins; Christopher D Gocke; James R Eshleman
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

4.  Non-reproducible sequence artifacts in FFPE tissue: an experience report.

Authors:  Richard Ofner; Cathrin Ritter; Selma Ugurel; Lorenzo Cerroni; Mathias Stiller; Thomas Bogenrieder; Flavio Solca; David Schrama; Jürgen C Becker
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-17       Impact factor: 4.553

5.  A guide to nucleic acid detection by single-molecule kinetic fingerprinting.

Authors:  Alexander Johnson-Buck; Jieming Li; Muneesh Tewari; Nils G Walter
Journal:  Methods       Date:  2018-08-10       Impact factor: 3.608

Review 6.  Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Authors:  Lawrence J Jennings; Maria E Arcila; Christopher Corless; Suzanne Kamel-Reid; Ira M Lubin; John Pfeifer; Robyn L Temple-Smolkin; Karl V Voelkerding; Marina N Nikiforova
Journal:  J Mol Diagn       Date:  2017-03-21       Impact factor: 5.568

7.  The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations.

Authors:  Masaya Suenaga; Beth Dudley; Eve Karloski; Michael Borges; Marcia Irene Canto; Randall E Brand; Michael Goggins
Journal:  Pancreas       Date:  2018-01       Impact factor: 3.327

Review 8.  Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations.

Authors:  Jesse J Salk; Michael W Schmitt; Lawrence A Loeb
Journal:  Nat Rev Genet       Date:  2018-03-26       Impact factor: 53.242

9.  Ultraspecific analyte detection by direct kinetic fingerprinting of single molecules.

Authors:  Tanmay Chatterjee; Zi Li; Kunal Khanna; Karen Montoya; Muneesh Tewari; Nils G Walter; Alexander Johnson-Buck
Journal:  Trends Analyt Chem       Date:  2019-12-04       Impact factor: 12.296

10.  How does inflammation drive mutagenesis in colorectal cancer?

Authors:  Chia Wei Hsu; Mark L Sowers; Willie Hsu; Eduardo Eyzaguirre; Suimin Qiu; Celia Chao; Charles P Mouton; Yuri Fofanov; Pomila Singh; Lawrence C Sowers
Journal:  Trends Cancer Res       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.